In this exciting episode, Norbert Bischofberger, PhD, CEO of Kronos Bio, reveals the secrets of Targeting Dysregulated Transcription through TRNs. Join Gino LaMont as they delve into Kronos Bio's cutting-edge research, with Nikolaus Obholzer, Director of Computational Biology, discussing the role of AI in action. Stay tuned for insights that could revolutionize the future of medicine!